New York City, NY – According to filings with the U.S. Securities and Exchange Commission, Elevation Oncology is raising $65,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Shawn Leland played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Elevation Oncology

Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. We make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. Together with our peers we work towards a future in which each unique genomic testing result can be matched with a purpose-built precision medicine to bring clarity to every cancer treatment journey.

To learn more about Elevation Oncology, visit http://elevationoncology.com/

Contact:
Shawn Leland, Chief Executive Officer
716-371-1125
https://www.linkedin.com/in/shawn-leland-66925b9/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved